Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer

Lei Wang,Diana L. Simons,Xuyang Lu,Travis Y. Tu,Shawn Solomon,Roger Wang,Anthony Rosario,Christian Avalos,Daniel Schmolze,John Yim,James Waisman,Peter P. Lee
DOI: https://doi.org/10.1038/s41590-019-0429-7
IF: 30.5
2019-07-08
Nature Immunology
Abstract:Regulatory T (T<sub>reg</sub>) cells play a major role in the development of an immunosuppressive tumor microenvironment. The origin of intratumoral T<sub>reg</sub> cells and their relationship with peripheral blood T<sub>reg</sub> cells remain unclear. T<sub>reg</sub> cells consist of at least three functionally distinct subpopulations. Here we show that peripheral blood CD45RA<sup>−</sup>FOXP3<sup>hi</sup> T<sub>reg</sub> cells (T<sub>reg</sub> II cells) are phenotypically closest to intratumoral T<sub>reg</sub> cells, including in their expression of CCR8. Analyses of T cell antigen receptor repertoires further support the hypothesis that intratumoral T<sub>reg</sub> cells may originate primarily from peripheral blood T<sub>reg</sub> II cells. Moreover, the signaling responsiveness of peripheral blood T<sub>reg</sub> II cells to immunosuppressive, T helper type 1 (T<sub>H</sub>1) and T helper type 2 (T<sub>H</sub>2) cytokines reflects intratumoral immunosuppressive potential, and predicts future relapse in two independent cohorts of patients with breast cancer. Together, our findings give important insights into the relationship between peripheral blood T<sub>reg</sub> cells and intratumoral T<sub>reg</sub> cells, and highlight cytokine signaling responsiveness as a key determinant of intratumoral immunosuppressive potential and clinical outcome.
immunology
What problem does this paper attempt to address?